Ligand validation:9HNK

DLZ: 1-deoxy-1-(6,7-dimethyl-2,4-dioxo-3,4-dihydropteridin-8(2H)-yl)-D-ribitol

DLZ is a Ligand Of Interest in 9HNK designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9HNK_DLZ_A_602	29%	21%	0.149	0.806	1.71	1.57	5	4	0	0	100%	0.76
9HNL_DLZ_A_602	63%	41%	0.092	0.886	1.07	1.2	2	3	0	0	100%	1
9Q8F_DLZ_A_602	59%	40%	0.102	0.882	1.02	1.32	1	4	1	0	100%	0.47
9HNN_DLZ_A_602	54%	43%	0.108	0.872	1.1	1.09	2	1	3	0	100%	1
9HNO_DLZ_A_602	26%	43%	0.15	0.788	1.08	1.13	2	1	3	0	100%	0.78
9HNM_DLZ_A_602	14%	27%	0.213	0.766	1.19	1.75	2	9	2	0	100%	0.99
6DD6_DLZ_A_602	95%	22%	0.058	0.961	1.13	2.07	1	13	3	0	100%	1
4DJA_DLZ_A_602	91%	12%	0.075	0.961	2.06	2	4	14	2	0	100%	1
3A3G_DLZ_A_191	91%	9%	0.091	0.977	2.12	2.27	5	11	0	0	100%	1
8A1H_DLZ_A_602	79%	12%	0.119	0.966	2.01	2.06	9	11	2	0	100%	1
5LFA_DLZ_A_602	70%	18%	0.14	0.957	1.3	2.2	1	13	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.